ASP Isotopes Inc. announced that it has entered into a definitive securities purchase agreement to issue 8,459,093 shares at a price of $0.9105 per share for the gross proceeds of $7,702,004.1765, 1,190,239 shares at a price $0.9548 for the gross proceeds of $1,136,440.1972 and 303,178 shares at a price $0.96 for the gross proceeds of $291,050.88 for the total gross proceeds of $9,129,495.2537 on October 9, 2023. The transaction will include participation from returning investor Tees River Critical Resources Fund Limited, and multiple members of the company?s board of directors. As a part of the transaction, the company may a fee equal to 5.0% of the aggregate gross proceeds from the shares sold that is $456,474.7626.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.31 USD | +11.66% | +14.63% | +140.78% |
May. 15 | ASP Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 10 | ASP Isotopes Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+140.78% | 221M | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- ASPI Stock
- News ASP Isotopes Inc.
- ASP Isotopes Inc. announced that it expects to receive $9.129495 million in funding from Tees River Critical Resources Fund Limited